A Study Of Blood Collection Tubes For Stabilization Of Nucleic Acids And Extracellular Vesicles

Overview

About this study

A study will be conducted to isolate extracellular vesicles (EVs) and nucleic acids (RNA) from human plasma. Concentration and quality metrics will be evaluated to determine the optimal tube type(s) for downstream experiments.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion/Exclusion Criteria:

  • Presumed healthy individuals

  • Not applicable, health status is not important in this initial optimization study

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 Eligibility last updated 08/25/2026. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Kirk Wangensteen, M.D., Ph.D.

Open for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions